FDA panel begins hearings on hepatitis C treatment

ipsita's picture
Submitted by ipsita on Wed, 1998-05-06 09:30

A Food and Drug Administration advisory panel began hearings on Monday on a new approach to hepatitis C by Schering-Plough Corp., that uses a combination of drugs to fight the virus and boost the

thesaurus: 
Health
Main Topic: 
Health
Name of the Newspaper: 
Business Line (New Delhi)
Mark Content Private(Internal): 
Clipping Type: 
DNB
External URL: 
Main Type: 
dte-DNB
Publication Date: 
06/05/1998